D. E. Shaw & Co., Inc. - ELOXX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$6,000
-50.0%
21,2950.0%0.00%
Q1 2022$12,000
-20.0%
21,2950.0%0.00%
Q4 2021$15,000
-85.6%
21,295
-66.6%
0.00%
Q3 2021$104,00063,6980.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,930,092$1,363,0000.55%
AMERICAN FINANCIAL GROUP INC 1,480,000$1,045,0000.29%
Vanguard Capital Wealth Advisors 158,900$111,0000.08%
Anson Funds Management LP 553,652$391,0000.04%
Nantahala Capital Management 894,659$632,0000.02%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$1,479,0000.02%
Harel Insurance Investments & Financial Services Ltd. 1,176,401$831,0000.02%
Atom Investors LP 113,151$80,0000.01%
Virtu Financial LLC 130,270$91,0000.01%
Altshuler Shaham Ltd 1,157,540$828,0000.01%
View complete list of ELOXX PHARMACEUTICALS INC shareholders